UBE3A: E3 ubiquitin-protein ligase which accepts ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and transfers it to its substrates. Several substrates have been identified including the RAD23A and RAD23B, MCM7 (which is involved in DNA replication), annexin A1, the PML tumor suppressor, and the cell cycle regulator p27Kip1. Additionally, may function as a cellular quality control ubiquitin ligase by helping the degradation of the cytoplasmic misfolded proteins. Finally, UBE3A also promotes its own degradation in vivo. Binds UBQLN1 and UBQLN2. Interacts with the 26S proteasome. Interacts with HCV core protein and targets it to degradation. Interacts with the E6 protein of the cancer- associated human papillomavirus types 16 and 18. The E6/E6-AP complex binds to and targets the p53/TP53 tumor-suppressor protein for ubiquitin-mediated proteolysis. Interacts with BPY2. 3 isoforms of the human protein are produced by alternative splicing.
Protein type: EC 6.3.2.19; Ubiquitin conjugating system; Ligase; Transcription, coactivator/corepressor; Nuclear receptor co-regulator; EC 6.3.2.-; Ubiquitin ligase
Chromosomal Location of Human Ortholog: 15q11.2
Cellular Component: proteasome complex; cytoplasm; nucleus; cytosol
Molecular Function: protein binding; transcription coactivator activity; ubiquitin-protein ligase activity; ligase activity
Biological Process: ubiquitin-dependent protein catabolic process; positive regulation of phosphoinositide 3-kinase cascade; protein autoubiquitination; viral reproduction; sperm entry; ovarian follicle development; protein ubiquitination during ubiquitin-dependent protein catabolic process; androgen receptor signaling pathway; positive regulation of transcription from RNA polymerase II promoter; brain development; regulation of circadian rhythm; proteolysis
Disease: Angelman Syndrome
Show more